1 / 3

Disease-Free Survival Analysis in Nasal and Non-Nasal Disseminated Lymphoma Patients

This study examines the disease-free survival and cumulative survival rates of lymphoma patients based on IPI and EBV DNA SMILE status. Results show significant survival differences based on nasal involvement, IPI scores, and EBV DNA SMILE positivity.

hermione-wright
Download Presentation

Disease-Free Survival Analysis in Nasal and Non-Nasal Disseminated Lymphoma Patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplemental file 4 Disease free survivals of the entire cohort of patients 100 100 Stage I 80 80 Stage II 60 60 Cumulative Survival (%) Cumulative Survival (%) 40 40 Stage IV 20 20 P = 0.033 80 80 20 20 40 40 60 60 100 100 Disease Free Survival (months) Disease Free Survival (months) A Disseminated Nasal P = 0.001 Non-nasal B

  2. 100 100 IPI = 0 P = 0.01 80 80 IPI = 1 IPI = 3 60 60 Cumulative Survival (%) Cumulative Survival (%) Negative EBV DNA SMILE (I) 40 40 IPI = 2 P < 0.001 20 20 Positive EBV DNA SMILE (I) IPI = 5 80 80 20 20 40 40 60 60 100 100 Disease Free Survival (months) Disease Free Survival (months) C D

  3. 100 KIPI = 2 KIPI = 0 80 KIPI = 1 60 Cumulative Survival (%) KIPI = 3 40 20 P = 0.024 KIPI = 4 80 20 40 60 100 Disease Free Survival (months) E

More Related